192 related articles for article (PubMed ID: 34375678)
1. A comparison of the monomeric [
Israel I; Elflein K; Schirbel A; Chen K; Samnick S
Eur J Pharm Sci; 2021 Nov; 166():105964. PubMed ID: 34375678
[TBL] [Abstract][Full Text] [Related]
2. In vivo assessment of aminopeptidase N (APN/CD13) specificity of different
Kis A; Dénes N; Szabó JP; Arató V; Jószai I; Enyedi KN; Lakatos S; Garai I; Mező G; Kertész I; Trencsényi G
Int J Pharm; 2020 Nov; 589():119881. PubMed ID: 32946975
[TBL] [Abstract][Full Text] [Related]
3.
Kis A; Dénes N; Szabó JP; Arató V; Beke L; Matolay O; Enyedi KN; Méhes G; Mező G; Bai P; Kertész I; Trencsényi G
Biomed Res Int; 2021; 2021():6642973. PubMed ID: 33778075
[TBL] [Abstract][Full Text] [Related]
4. In vivo imaging of Aminopeptidase N (CD13) receptors in experimental renal tumors using the novel radiotracer (68)Ga-NOTA-c(NGR).
Máté G; Kertész I; Enyedi KN; Mező G; Angyal J; Vasas N; Kis A; Szabó É; Emri M; Bíró T; Galuska L; Trencsényi G
Eur J Pharm Sci; 2015 Mar; 69():61-71. PubMed ID: 25592229
[TBL] [Abstract][Full Text] [Related]
5. 68Ga-DOTA-NGR as a novel molecular probe for APN-positive tumor imaging using MicroPET.
Zhang J; Lu X; Wan N; Hua Z; Wang Z; Huang H; Yang M; Wang F
Nucl Med Biol; 2014 Mar; 41(3):268-75. PubMed ID: 24438818
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of an Integrin α
Gai Y; Jiang Y; Long Y; Sun L; Liu Q; Qin C; Zhang Y; Zeng D; Lan X
Mol Pharm; 2020 Jan; 17(1):349-358. PubMed ID: 31829615
[TBL] [Abstract][Full Text] [Related]
7.
Farkasinszky G; Dénes N; Rácz S; Kis A; Péliné JS; Opposits G; Veres G; Balkay L; Kertész I; Mező G; Hunyadi J; Trencsényi G
In Vivo; 2022; 36(2):657-666. PubMed ID: 35241519
[TBL] [Abstract][Full Text] [Related]
8.
Kis A; Szabó JP; Dénes N; Vágner A; Nagy G; Garai I; Fekete A; Szikra D; Hajdu I; Matolay O; Méhes G; Mező G; Kertész I; Trencsényi G
Biomed Res Int; 2020; 2020():4952372. PubMed ID: 32832549
[TBL] [Abstract][Full Text] [Related]
9. 68Ga-labeled cyclic NGR peptide for microPET imaging of CD13 receptor expression.
Shao Y; Liang W; Kang F; Yang W; Ma X; Li G; Zong S; Chen K; Wang J
Molecules; 2014 Aug; 19(8):11600-12. PubMed ID: 25100253
[TBL] [Abstract][Full Text] [Related]
10.
Szabo JP; Denes N; Arato V; Racz S; Kis A; Opposits G; Kepes Z; Hajdu I; Joszai I; Emri M; Kertesz I; Mezo G; Trencsenyi G
In Vivo; 2022; 36(4):1667-1675. PubMed ID: 35738627
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of
Yang Y; Zhang J; Zou H; Shen Y; Deng S; Wu Y
J Cancer; 2021; 12(1):244-252. PubMed ID: 33391421
[No Abstract] [Full Text] [Related]
12. Synthesis and evaluation of 64Cu-labeled monomeric and dimeric NGR peptides for MicroPET imaging of CD13 receptor expression.
Chen K; Ma W; Li G; Wang J; Yang W; Yap LP; Hughes LD; Park R; Conti PS
Mol Pharm; 2013 Jan; 10(1):417-27. PubMed ID: 23190134
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of
Satpati D; Sharma R; Sarma HD; Dash A
Chem Biol Drug Des; 2018 Mar; 91(3):781-788. PubMed ID: 29130625
[TBL] [Abstract][Full Text] [Related]
14. Preclinical evaluation of a dual-receptor targeted tracer [
Lv X; Song X; Long Y; Zeng D; Lan X; Gai Y
Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):54-67. PubMed ID: 37642706
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of
Zhao M; Yang W; Zhang M; Li G; Wang S; Wang Z; Ma X; Kang F; Wang J
Tumour Biol; 2016 Sep; 37(9):12123-12131. PubMed ID: 27220318
[TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of
Liu Q; Cai S; Ye J; Xie Q; Liu R; Qiu L; Lin J
Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1826-1840. PubMed ID: 38319321
[TBL] [Abstract][Full Text] [Related]
17. Development of novel peptide-based radiotracers for detecting PD-L1 expression and guiding cancer immunotherapy.
Zhu S; Liang B; Zhou Y; Chen Y; Fu J; Qiu L; Lin J
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):625-640. PubMed ID: 37878029
[TBL] [Abstract][Full Text] [Related]
18. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers.
Persson M; Madsen J; Østergaard S; Ploug M; Kjaer A
Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391
[TBL] [Abstract][Full Text] [Related]
19. N-terminal modifications improve the receptor affinity and pharmacokinetics of radiolabeled peptidic gastrin-releasing peptide receptor antagonists: examples of 68Ga- and 64Cu-labeled peptides for PET imaging.
Gourni E; Mansi R; Jamous M; Waser B; Smerling C; Burian A; Buchegger F; Reubi JC; Maecke HR
J Nucl Med; 2014 Oct; 55(10):1719-25. PubMed ID: 25146125
[TBL] [Abstract][Full Text] [Related]
20. Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and (64)Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors.
Oxboel J; Brandt-Larsen M; Schjoeth-Eskesen C; Myschetzky R; El-Ali HH; Madsen J; Kjaer A
Nucl Med Biol; 2014 Mar; 41(3):259-67. PubMed ID: 24417983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
